Trials / Conditions / Progressive Disease

Progressive Disease

13 registered clinical trials studyying Progressive Disease — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Oral Tacrolimus vs Dexamethasone Micro-pulse Therapy in Pediatric Rapidly Progressing Vitiligo: A Multicenter NCT06900777	Xijing Hospital	N/A
Recruiting	Assessment of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated N NCT04954820	Institut du Cancer de Montpellier - Val d'Aurelle	Phase 2
Withdrawn	CPI-613 and Hydroxychloroquine for Patients With High Risk Myelodysplastic Syndrome NCT03929211	Wake Forest University Health Sciences	Phase 1 / Phase 2
Terminated	Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients Wit NCT04205838	Jonsson Comprehensive Cancer Center	Phase 2
Terminated	Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung NCT04005144	University of California, San Francisco	Phase 1
Active Not Recruiting	Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who NCT03546426	Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS	Phase 1
Unknown	sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer NCT04033432	Northwestern University	Phase 2
Completed	Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma NCT03990571	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unres NCT04017650	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Withdrawn	Modified Immune Cells (CD19-CD22 CAR T Cells) in Treating Patients With Recurrent or Refractory CD19 Positive, NCT04029038	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Active Not Recruiting	Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fall NCT03586661	M.D. Anderson Cancer Center	Phase 1
Completed	Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer NCT03154190	Stanford University	N/A
Completed	Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent o NCT01737450	Centre Leon Berard	Phase 2